Low-dose aspirin was associated with an increased risk of cardiovascular events in patients with chronic kidney disease and low bodyweight: results from KNOW-CKD study

The benefits and risks of aspirin therapy for patients with chronic kidney disease (CKD) who have a high burden of cardiovascular events (CVE) are controversial. To examine the effects of low-dose aspirin on major clinical outcomes in patients with CKD. As a prospective observational cohort study, u...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Yun Jung, Kim, Ae Jin, Ro, Han, Chang, Jae Hyun, Lee, Hyun Hee, Chung, Wookyung, Hyun, Young Youl, Lee, Joongyub, Kim, Yeong Hoon, Han, Seung Hyeok, Chae, Dong-Wan, Ahn, Curie, Oh, Kook-Hwan, Jung, Ji Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988000/
https://www.ncbi.nlm.nih.gov/pubmed/33758303
http://dx.doi.org/10.1038/s41598-021-86192-4

Ejemplares similares

Ejemplares similares